Skip to main content

Pharma News

pharma courses

 

gpat

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Organogold (III) complex accumulates in mitochondria of lung cancer cells

    Precious metals are not merely ornaments; they are also important components of pharmaceuticals, like the antitumor drug cisplatin. Recently, the search for alternatives with improved activity has begun to focus on gold. In the journal Angewandte Chemie, a French research team has now published the first study about the speciation and distribution of an organogold(III) complex in cancer cells and reveals how specially designed “organogold” complexes might open exciting avenues for fighting cancer. 

  • KAIST Develops Retinal Therapy to Restore Lost Vision​

    Vision is one of the most crucial human senses, yet over 300 million people worldwide are at risk of vision loss due to various retinal diseases. While recent advancements in retinal disease treatments have successfully slowed disease progression, no effective therapy has been developed to restore already lost vision until now. KAIST researchers have successfully developed a novel drug to restore vision.

  • First guideline on newborn screening for cystic fibrosis calls for changes in practice to improve outcomes

    The United States Cystic Fibrosis Foundation released the first guideline on newborn screening for cystic fibrosis (CF), in order to improve timely detection of CF in infants from all racial and ethnic backgrounds. The new guideline, based on systematic literature reviews and published in the International Journal of Neonatal Screening, reflects rigorous scientific investigation and perspectives from parents, CF specialists, public health representatives, primary care providers and genetic counselors.

  • Academically achieves monumental success in the first ever OPRA Examination

    Academically is a leading healthcare edtech platform with global operations. It serves as a one-stop solution helping global healthcare professionals prepare for international licensure exams. With a proven success rate and an unbeatable track record, Academically continues to empower thousands of healthcare professionals in achieving their global career goals.

  • How healthy microbes in infancy reduce diabetes risk
    Exposure to antibiotics during a key developmental window in infancy can stunt the growth of insulin-producing cells in the pancreas and may boost risk of diabetes later in life, new research in mice suggests. The study, published this month in the journal Science, also pinpoints specific microorganisms that may help those critical cells proliferate in early life.
  • mRNA-based COVID-19 vaccines train the ‘long-term memory’ of the immune system
    Researchers at the University of Cologne have discovered that mRNA-based COVID-19 vaccines have a persistent effect on the innate immune system. These mechanisms may help the human body to better protect itself against potential future infections / publication in Molecular Systems Biology
  • Aspen Biopharma Labs gets warning letter from USFDA
    The U.S. Food and Drug Administration inspected Aspen Biopharma Labs Private Limited, drug facility; at Rangareddy region from September 16 to September 21, 2024. And they get a warning letter which summarizes significant deviations from Current Good Manufacturing Practice CGMP for active pharmaceutical ingredients.
  • Growing Body of Evidence Links HPV with Heart Disease
    In addition to causing several types of cancer, human papillomavirus appears to bring a significantly increased risk of heart disease and coronary artery disease, according to a study being presented at the American College of Cardiology's Annual Scientific Session.
  • New Evidence Links Microplastics with Chronic Disease

    Tiny fragments of plastic have become ubiquitous in our environment and our bodies. Higher exposure to these microplastics, which can be inadvertently consumed or inhaled, is associated with a heightened prevalence of chronic noncommunicable diseases, according to new research being presented at the American College of Cardiology's Annual Scientific Session (ACC.25).

  • Blujepa (gepotidacin) approved by USFDA for treatment of uncomplicated urinary tract infections
    Discovered by GSK scientists, Blujepa is a first-in-class oral antibiotic with a novel mechanism of action that is part of GSK’s infectious diseases portfolio.
Subscribe to Pharma News